gsk

Nvidia, AMD and Arm provide updates on their AI processor plans. (0:16) NYSE trading glitch show Berkshire Hathaway down 99%. (1:45) JPMorgan weighs in on the restaurant sector. (2:52)

Show Notes
'Sell in May and go away' didn't work (again) but that's good for the year
ISM Manufacturing PMI declines in May for a second month in disappointing print
Waste Management confirms deal to buy Stericycle for $62/share

Episode transcripts seekingalpha.com/wsb
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

Attorney Brent Wisner discusses legal actions against the corporation that made heartburn medication Zantac.

The trial-ready team of attorneys at Baum Hedlund Aristei & Goldman intend to hold the makers of Zantac accountable for allegedly concealing the ranitidine cancer link. With more than $4 billion in verdicts and settlements won across all practice areas, we have the experience and track record needed to secure maximum compensation for our clients.

For more info: https://www.baumhedlundlaw.com/prescription-drugs/zantac-cancer-lawsuit/

--- Send in a voice message: https://podcasters.spotify.com/pod/show/rfkjr/message